AVNS (AVNS)
Avanos Medical, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America.
Its comprehensive product array targets two primary areas: chronic care and non-opioid pain management. Within chronic care, the company provides digestive health offerings such as Mic-Key enteral feeding tubes, Corpak patient feeding systems, and NeoMed solutions tailored for neonatal and pediatric patients.
Its respiratory health segment includes closed airway suction systems and other airway management devices, marketed under prominent brands like Ballard, Microcuff, and Endoclear. For non-opioid pain relief, Avanos offers acute pain solutions, including On-Q and ambIT surgical pain pumps, along with Game Ready cold and compression therapy systems.
It also features interventional pain solutions, providing minimally invasive therapies like Coolief for long-term pain alleviation.
The company facilitates product access by selling directly to hospitals, various healthcare providers, and end-user facilities, in addition to utilizing third-party wholesale distributors. Originally incorporated in 2014 and known as Halyard Health, Inc., the company officially adopted the name Avanos Medical, Inc. in June 2018 and maintains its headquarters in Alpharetta, Georgia.
Leadership
David C. Pacitti
Chief Executive Officer & Director
Sigfrido Delgado
Senior Vice President of Operations
Jason Pickett
Vice President of Corporate Finance & Treasurer
Scott Michael Galovan
Chief Financial Officer & Senior Vice President
Employees
2K+
Country
US
Sector
Healthcare
Website
avanos.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| SVP, Operations | Grant/Award | 54.9K | -- | Jul 27, 2026 | |
| Chief Executive Officer | Grant/Award | 444.7K | -- | Jul 27, 2026 | |
| Chief Executive Officer | Withholding/Transfer | 444.7K | $11.12M | Jul 27, 2026 | |
| SVP, Chief Financial Officer | Withholding/Transfer | 135.6K | $3.39M | Jul 27, 2026 | |
| SVP, Chief Financial Officer | Grant/Award | 96.1K | -- | Jul 27, 2026 | |
| SVP, Chief Financial Officer | Withholding/Transfer | 96.1K | $2.40M | Jul 27, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
BlackRock, Inc. | 7.5M | -- | 13F |
BlackRock, Inc. · also on 13F· may incl. warrants· filed Apr 2025 | 6.8M | 14.8% | 13G |
T. Rowe Price Investment Management, Inc. · filed May 2026 | 5.3M | 11.5% | 13G |
NEXPOINT ASSET MANAGEMENT, L.P. | 2.2M | -- | 13F |
Dimensional Fund Advisors LP · also on 13F· may incl. warrants· filed Jan 2026 | 2.2M | 4.6% | 13G |
STATE STREET CORP | 2.0M | -- | 13F |
Armistice Capital, LLC · filed May 2026 | 2.0M | 4.3% | 13G |
VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | -- | 13F |
TIG Advisors, LLC | 1.7M | -- | 13F |
Paradice Investment Management LLC · filed Feb 2024 | 1.7M | 3.6% | 13G |
Insiders
- Delgado SigfridoSVP, Operations
- Pacitti DavidChief Executive Officer
- Galovan Scott MichaelSVP, Chief Financial Officer
- Franchini Indrani LallDirector
- OLEARY PATRICK JDirector
- Egbuonu-Davis LisaDirector
- BLACKFORD GARYDirector
- Shimer Julie AnnDirector
- Hurley John JosephPrincipal Accounting Officer
- Holbrook KerrSVP, Chief Commercial Officer
30d Avg
--
60d Avg
--
90d Avg
--